The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynthomer Regulatory News (SYNT)

Share Price Information for Synthomer (SYNT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 291.50
Bid: 293.50
Ask: 295.00
Change: -10.50 (-3.48%)
Spread: 1.50 (0.511%)
Open: 300.00
High: 304.00
Low: 291.50
Prev. Close: 302.00
SYNT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Q1 Trading Update

21 Apr 2021 07:00

RNS Number : 0778W
Synthomer PLC
21 April 2021
 

 

21st April 2021

 

Synthomer plc

 

Q1 Trading Update

 

Stronger underlying trading across all divisions and continued exceptional Nitrile Latex performance

 

Synthomer plc ('Synthomer' or 'the Group') today issues a trading update for the quarter ended 31st March 2021.

 

Strong trading momentum across all businesses

 

Performance Elastomers

 

Performance Elastomers has continued to perform strongly. The positive trends experienced in our Nitrile Latex business during 2020 have continued through the first quarter of 2021 with overall performance ahead of expectations. Both volumes and unit margins were significantly ahead of prior year driven by exceptional demand as a consequence of the COVID-19 pandemic.

 

Conditions in our SBR latex business also continued to improve, with all segments except paper trading ahead of the comparative period in 2020. Following the strategic review of the European SBR network we completed the consultation in Marl (Germany) and the planned closure of the Oulu (Finland) site at the end of Q1.

 

Functional Solutions

 

Functional Solutions has seen a sustained improvement in the first quarter of 2021. Our consumer facing and industrial end markets have remained robust with our Oil and Gas business improving month on month. Volumes and unit margins were ahead of the comparative period supported by the acquisition of and synergies from OMNOVA and the introduction of low cost capacity in Europe and the US to drive organic growth in differentiated applications.

 

Industrial Specialities and Acrylate Monomers

 

Industrial Specialities also had a good start to the year with activity levels and unit margins significantly ahead of prior year in all major segments including automotive and consumer facing markets. Acrylate Monomers likewise benefitted from improved demand and industry supply issues resulting in a significant uplift in profitability.

 

Reducing Leverage

 

The strong trading performance and cash generation has resulted in a further reduction in proforma net debt:EBITDA to 1.2x at 31st March 2021 with anticipated leverage of less than 1.0x expected by 30th June 2021 (31st December 2020: 1.8x).

 

 

Positive outlook: strong trading increases FY EBITDA expectations

 

Whilst macroeconomic conditions remain uncertain given the ongoing COVID-19 pandemic, we are encouraged by a further strengthening of underlying trading conditions and the strong performances across all our divisions during Q1.

 

Accordingly, the Board now expects 2021 EBITDA to be in excess of £450m reflecting a further rise in the one off profitability of our Nitrile Latex business and the strengthening of the underlying trading conditions. Our expectation that the Nitrile Latex business will return to more normalised levels in 2022 remains unchanged.

 

Conference call

The company will hold a conference call for investors and analysts at 0800 BST today:

 

Dial in number:

UK (Toll free) 0800 640 6441

UK (Local) 020 3936 2999

United States (Local) 1 646 664 1960

All other locations +44 20 3936 2999

 

Access code: 921802

 

 

-ENDS-

 

Further information:

 

Calum MacLean, Chief Executive Officer

Steve Bennett, Chief Financial Officer Tel: +44 1279 436211

Tim Hughes, President, Corporate Development

 

Charles Armitstead/ Matt Denham, Teneo Tel: +44 7703 330 269/ +44 7825 735596

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTIMMATMTTTBAB
Date   Source Headline
1st Jul 20167:00 amRNSCompletion of acquisition and trading update
31st May 201611:31 amRNSAudit Tender
16th May 20164:17 pmRNSHolding(s) in Company
9th May 201612:31 pmRNSDirector/PDMR Shareholding
28th Apr 20163:11 pmRNSResult of AGM
28th Apr 20167:00 amRNSQ1 Trading update
21st Apr 20161:44 pmRNSHolding(s) in Company
20th Apr 20162:23 pmRNSDirector Declaration
11th Apr 20163:01 pmRNSDirector/PDMR Shareholding
11th Apr 20163:00 pmRNSDirector/PDMR Shareholding
31st Mar 20162:15 pmRNSAnnual Financial Report
21st Mar 20167:00 amRNSAcquisition
21st Mar 20167:00 amRNSDisposal
15th Mar 201612:29 pmRNSHolding(s) in Company
2nd Mar 20167:00 amRNSPreliminary Results for the year ended 31 Dec 2015
10th Feb 20167:00 amRNSFRS 101 Notification
5th Feb 20163:34 pmRNSHolding(s) in Company
5th Feb 20163:13 pmRNSHolding(s) in Company
30th Nov 20153:00 pmRNSHolding(s) in Company
18th Nov 201510:30 amRNSDirector/PDMR Shareholding
6th Nov 20157:00 amRNSQ3 Trading Update
1st Oct 201512:50 pmRNSHolding(s) in Company
13th Aug 201510:05 amRNSHolding(s) in Company
11th Aug 20157:00 amRNSHalf Yearly Results
10th Jul 20152:43 pmRNSDirector/PDMR Shareholding
9th Jul 20159:12 amRNSHolding(s) in Company
7th Jul 20154:21 pmRNSHolding(s) in Company
6th Jul 20153:59 pmRNSHolding(s) in Company
2nd Jul 20157:00 amRNSTrading Update
22nd Jun 20153:51 pmRNSHolding(s) in Company
20th May 20158:57 amRNSHolding(s) in Company
14th May 201510:02 amRNSDirector/PDMR Shareholding
30th Apr 201512:53 pmRNSResult of AGM
30th Apr 201512:46 pmRNSDirectorate Change
30th Apr 20157:00 amRNSQuarter 1 Trading Update
27th Apr 201510:36 amRNSDirectorate Change
21st Apr 20155:16 pmRNSHolding(s) in Company
1st Apr 20158:15 amRNSDirectorate Change
31st Mar 20159:25 amRNSAnnual Financial Report
30th Mar 201510:13 amRNSHolding(s) in Company
27th Mar 201512:53 pmRNSDirector/PDMR Shareholding
23rd Mar 20157:00 amRNSDirectorate Change
19th Mar 201511:53 amRNSDirector Declaration
18th Mar 20154:47 pmRNSDirector/PDMR Shareholding
13th Mar 20159:35 amRNSHolding(s) in Company
27th Feb 20153:06 pmRNSDirector/PDMR Shareholding
27th Feb 20153:05 pmRNSDirector/PDMR Shareholding
26th Feb 20157:01 amRNSFinal Results
20th Jan 20151:58 pmRNSNotice of Results
16th Jan 20157:00 amRNSTrading update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.